Best Colonoscopy Colonoscopy in Israel: TOP 17 doctors

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

With over two decades of experience, the doctor specializes in diagnosing and treating gastrointestinal diseases, including pancreas inflammation, cystic formations, and intestinal diverticulitis. The doctor also offers overweight treatment and has contributed significantly to the field with 85 published scientific papers.

Graduating from the Medical University in Kazakhstan, the doctor completed residency and advanced specialization at the First Medical Center in Tel Aviv. The doctor provides treatments for Crohn's disease, stomach ulcers, and gastrointestinal cancer, and performs procedures like video capsule endoscopy.

The doctor is a top gastroenterologist and hematologist with over 50 years of experience, specializing in liver conditions. The doctor is recognized as a leading liver expert at Ichilov Medical Center, focusing on the treatment and diagnosis of chronic hepatitis, autoimmune, and genetic liver diseases.

The doctor heads the Liver Unit at Sourasky Medical Center and has a medical degree from the Hebrew University and a specialty in gastroenterology from the Hebrew University Hadassah Medical School. The doctor has authored over 60 publications and presented at 100 conferences.

Memberships include the Israeli Gastroenterology Association and the American and European Associations for the Study of the Liver.

The doctor is a top-rated Israeli gastroenterologist specializing in the treatment of gastrointestinal tract and liver diseases. Notably, the doctor was the first in Israel to utilize interventional ultrasound and is a co-founder of the European Society of Gastrointestinal Endoscopy.

The doctor heads the Gastroenterological Department at Sourasky Medical Center and has a profound expertise in diagnostics and treatment of gastric, liver, and pancreas diseases. Previously, the doctor directed the Interventional Endoscopy Unit at the same center and served as Deputy Director of the Internal Medicine Unit at Beilinson Hospital.

The doctor is a member of several prestigious organizations, including the American Gastroenterological Association and the European Association of Gastroenterology, Endoscopy and Nutrition.

The doctor graduated from Sackler Faculty of Medicine, Tel Aviv University, specializing in Internal Medicine and Gastroenterology. Further training was completed in immunology, microbiology, and inflammatory bowel diseases at the University of North Carolina, Chapel Hill.

Currently, the doctor serves as a Senior Physician at the Institute of Gastrointestinal and Liver Diseases, and directs both the Bacteriotherapies Clinic and the Department of Inflammatory Bowel Diseases at Tel Aviv Medical Center.

With over 80 professional publications and participation in more than 60 conferences, the doctor is a recognized expert in inflammatory bowel disease and bacterotherapy.

The doctor is a leading gastroenterologist in Israel with over 40 years of clinical experience. Specializing in the treatment of acute and chronic diseases of the esophagus, stomach, intestines, pancreas, and gastrointestinal cancer, the doctor is also an expert in hepatology, addressing biliary duct and liver abnormalities, as well as metabolic disorders. The doctor employs the latest medical treatments for viral hepatitis B and C.

Currently, the doctor serves as the chief gastroenterologist at Sourasky Medical Center and has also worked at Wolfson Medical Center. The doctor graduated from the Medical Faculty at Tel Aviv University and is a member of several prestigious medical associations.

The doctor specializes in managing pediatric inflammatory bowel diseases, celiac disease, and eosinophilic esophagitis, with expertise in performing endoscopic procedures in children.

Graduated from Tel Aviv University, Sackler Faculty of Medicine, and completed a Pediatrics Residency and Pediatric Gastroenterology Fellowship at Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center.

Active in academia as a lecturer and tutor, contributing to postgraduate and undergraduate medical education. A member of multiple professional societies, including the Israel Society for Pediatric Gastroenterology and Nutrition and the European Society of Pediatric Gastroenterology, Hepatology and Nutrition.

The doctor graduated from Hebrew University School of Medicine in 1987 and specializes in Surgery and Colorectal Surgery. Affiliated with Hadassah Medical Center, the doctor has been an Instructor in Surgery since 1995, a Lecturer since 1999, and a Senior Lecturer since 2005. The doctor has directed the Medical Students Program in the Department of Surgery since 1997 and has been the Residency Program Director in the Department of Surgery since 2000. Board certified in General Surgery in Israel since 1998, the doctor is also a member of various surgical associations.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.